TopMedTalk

TopMedTalk is at the American Association of Nurse Anaesthetists (AANA) 2018 in Boston. After an incredible year for the organisation and we were delighted to be able to get some time with the association's incoming President.

Desiree Chappell speaks with her guest Garry Brydges, DNP, MSN, MBA,CRNA, ACNP-BC, Chief Nurse Anesthetist at UT MD Anderson Cancer Center-Department of Anesthesiology and Perioperative Medicine and incoming President of the AANA.

TopMedTalk is at the American Association of Nurse Anaesthetists (AANA) 2018 conference in Boston. It has been an incredible year for the organisation and we were delighted to be able to get some time with the association's current outgoing President. Here Desiree Chappell sits down with her guest Dr Bruce Weiner, Adjunct Faculty at the University of South Florida, Clinician at Envision Healthcare and President of the AANA.

TopMedTalk is at the American Association of Nurse Anaesthetists (AANA) 2018 conference in Boston. It has been an incredible year for the organisation and we were delighted to be able to get some time with the association's current outgoing President.

Here Desiree Chappell sits down with her guest Dr Bruce Weiner, Adjunct Faculty at the University of South Florida, Clinician at Envision Healthcare and President of the AANA.

The Enhanced Perioperative Care for High-risk patients (EPOCH) trial results, as revealed at EBPOM 2018, show no change in mortality rates either on a 90 day or 180 day scale. What does this mean as regards the drive towards quality improvement in perioperative healthcare? For more on this we highly recommend you listen to these two podcasts here: The Epoch Trial Results: https://www.topmedtalk.com/ebpom-2018-8-the-epoch-trial-results/ The Dawn of a new EPOCH: https://www.topmedtalk.com/ebpom-2018-9-the-dawn-of-a-new-epoch/ Further light at the end of the tunnel is found in this piece about The Emergency Laparotomy Collaborative (ELC) which Monty mentions during the podcast: https://www.topmedtalk.com/ebpom-2018-emergency-lapartoomy-collaborative/ Presented by Monty Mythen and Desiree Chappell with contributions from Rupert Pearse, Professor of Intensive Care Medicine at Queen Mary, University of London, Nial Quiney, Consultant Anaesthetist at Royal Surrey County Hospital and Principal investigator for the Emergency Laparotomy Quality Improvement Care Bundle (ELPQuiC) project and Clinical Lead for the Emergency Laparotomy Collaborative (ELC), Carole Peden, Professor of Anesthesiology and Executive Director of the Center for Health System Innovation, University of Southern California, University of Bath and the Institute for Healthcare Improvement (IHI), Ramani Moonesinghe, Director of the UK National Institute of Academic Anaesthesia Health Services Research Centre. This special programme was originally streamed live on www.topmedtalk.com - if you missed it you're obviously not yet signed up to our newsletter! Remedy the situation, for free, now by either going to the website www.topmedtalk.com or following this link to sign up directly: https://www.topmedtalk.com/sign-up/

The Enhanced Perioperative Care for High-risk patients (EPOCH) trial results, as revealed at EBPOM 2018, show no change in mortality rates either on a 90 day or 180 day scale. What does this mean as regards the drive towards quality improvement in perioperative healthcare?
 
For more on this we highly recommend you listen to these two podcasts here:
 
The Epoch Trial Results: https://www.topmedtalk.com/ebpom-2018-8-the-epoch-trial-results/
 
The Dawn of a new EPOCH: https://www.topmedtalk.com/ebpom-2018-9-the-dawn-of-a-new-epoch/
 
Further light at the end of the tunnel is found in this piece about The Emergency Laparotomy Collaborative (ELC) which Monty mentions during the podcast: https://www.topmedtalk.com/ebpom-2018-emergency-lapartoomy-collaborative/
 
Presented by Monty Mythen and Desiree Chappell with contributions from Rupert Pearse, Professor of Intensive Care Medicine at Queen Mary, University of London, Nial Quiney, Consultant Anaesthetist at Royal Surrey County Hospital and Principal investigator for the Emergency Laparotomy Quality Improvement Care Bundle (ELPQuiC) project and Clinical Lead for the Emergency Laparotomy Collaborative (ELC), Carole Peden, Professor of Anesthesiology and Executive Director of the Center for Health System Innovation, University of Southern California, University of Bath and the Institute for Healthcare Improvement (IHI), Ramani Moonesinghe, Director of the UK National Institute of Academic Anaesthesia Health Services Research Centre.
 
This special programme was originally streamed live on www.topmedtalk.com - if you missed it you're obviously not yet signed up to our newsletter! Remedy the situation, for free, now by either going to the website www.topmedtalk.com or following this link to sign up directly: https://www.topmedtalk.com/sign-up/

Here Monty and Desiree present part of Professor Paul Myles's EBPOM 2018 presentation regarding the RELIEF trial, a massive part of the perioperative calendar this year. What are the consequences of this trial for the practice of Enhanced Recovery After Surgery (ERAS)? Also hear more about the follow up trial which will be looking at Acute Kidney Injury (AKI). This then leads to discussion of the OPTIMISE II trial.

Discussion then leads into the FEDORA trial and the IMPRESS trial with a clip of Monty's talk from EBPOM 2018.

Presented by Monty Mythen and Desiree Chappell with contributions from Professor Paul Myles Head of Alfred Health's and Monash University's Department of Anaesthesia and Perioperative Medicine and Professor Rupert Pearse, Intensive Care Medicine at Queen Mary, University of London.

This special programme was originally streamed live on www.topmedtalk.com - if you missed it you're obviously not yet signed up to our newsletter. Go to the website or follow this link: https://www.topmedtalk.com/sign-up/

Here Monty and Desiree present part of Professor Paul Myles's EBPOM 2018 presentation regarding the RELIEF trial, a massive part of the perioperative calendar this year. What are the consequences of this trial for the practice of Enhanced Recovery After Surgery (ERAS)? Also hear more about the follow up trial which will be looking at Acute Kidney Injury (AKI). This then leads to discussion of the OPTIMISE II trial.

Discussion then leads into the FEDORA trial and the IMPRESS trial with a clip of Monty's talk from EBPOM 2018.

Presented by Monty Mythen and Desiree Chappell with contributions from Professor Paul Myles Head of Alfred Health's and Monash University's Department of Anaesthesia and Perioperative Medicine and Professor Rupert Pearse, Intensive Care Medicine at Queen Mary, University of London.

This special programme was originally streamed live on www.topmedtalk.com - if you missed it you're obviously not yet signed up to our newsletter. Go to the website or follow this link: https://www.topmedtalk.com/sign-up/

Is there a global shortfall of anesthesia providers? How do we widen the number of people in the profession, both nationally and internationally?

TopMedTalk is at the AANA 2018 conference in Boston and will be sharing podcasts from the meeting with you over the next several days.

In this piece Desiree Chappell and Monty Mythen talk with Josh Newman, CRNA and Randy Moore, CRNA and CEO of the American association of Nurse Anesthetists.